Snapshot img

Medical Devices Market Size 2025-2029

The medical devices market size is forecast to increase by USD 223 billion, at a CAGR of 6.5% between 2024 and 2029. The market is witnessing significant growth, driven by the increasing prevalence of diseases and the emergence of innovative medical technologies. The market is experiencing a surge in demand due to the rising burden of chronic diseases and the growing aging population.

Major Market Trends & Insights

North America dominated the market and accounted for a 37% share in 2023.
The market is expected to grow significantly in Europe region as well over the forecast period.
Based on the End-user, the hospitals and ASCs segment led the market and was valued at USD 430.60 billion of the global revenue in 2023.
Based on the Product Type, the diagnostic devices segment accounted for the largest market revenue share in 2023.

Market Size & Forecast

Market Opportunities: USD 597.90 Billion
Future Opportunities: USD 223 Billion
CAGR (2024-2029): 6.5%
North America: Largest market in 2023

The market continues to evolve, driven by advancements in technology and the growing demand for innovative solutions across various sectors. Cardiovascular device technology, for instance, has seen significant progress with the development of more efficient and effective stents, leading to a 5% annual growth rate. Surgical instrument design has been revolutionized by surgical robotics systems, enabling minimally invasive procedures and improved therapeutic device efficacy. Three-dimensional printed implants are another area of focus, with biomaterial compatibility testing ensuring optimal patient safety and long-term success. Regulatory device compliance remains a critical factor, as mobile health applications and artificial intelligence diagnostics gain popularity.

What will be the Size of the Medical Devices Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

Advanced medical devices, such as implantable devices and diagnostic equipment, are increasingly being adopted to improve patient outcomes and enhance the quality of healthcare. However, the market faces challenges in the form of declining reimbursement and cost containment measures. Healthcare providers and insurers are increasingly focusing on cost savings, leading to pressure on medical device manufacturers to reduce prices. The clinics segment is the second largest segment of the end-user and was valued at USD 104.10 billion in 2023.

Additionally, regulatory compliance and stringent approval processes pose significant challenges to market entrants. Companies must navigate these challenges by developing cost-effective solutions, focusing on regulatory compliance, and collaborating with healthcare providers and insurers to ensure reimbursement for their products. To capitalize on the market opportunities and stay competitive, companies must invest in research and development to bring innovative products to market and collaborate with healthcare providers to address unmet clinical needs.

Neurological device implantation and in-vitro diagnostic testing are also seeing advancements, with precision medicine devices and machine learning algorithms driving diagnostic accuracy. In the realm of diabetes management systems, remote patient monitoring and wearable health trackers are transforming care delivery. Respiratory device performance and drug delivery systems are being optimized for better patient outcomes. Advanced wound care and rehabilitation device technology are also making strides, with connected medical devices and telemedicine platforms facilitating remote care. The market for implantable devices, such as orthopedic implants, is expected to grow at a steady pace, driven by improvements in implantable device design and device cybersecurity standards.

Biomedical device sterilization methods continue to evolve, ensuring patient safety and reducing the risk of infection. A notable example of market dynamism is the integration of health data analytics into clinical trial protocols and patient safety protocols, streamlining research and improving patient care. Overall, the market is characterized by continuous innovation and adaptation to meet the evolving needs of healthcare providers and patients.

How is this Medical Devices Industry segmented?

The medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Hospitals and ASCs
  Clinics
  Others


Product Type

  Diagnostic devices
  Therapeutic devices
  Monitoring devices
  Assistive and rehabilitation devices
  Others


Application

  Cardiovascular
  Ort

The global sales of homecare medical devices are estimated to be worth USD 172.6 billion in 2025 and are anticipated to reach a value of USD 403.4 billion by 2035.

Attributes	Key Insights
Historical Size, 2024	USD 158.5 billion
Estimated Size, 2025	USD 172.6 billion
Projected Size, 2035	USD 403.4 billion
Value-based CAGR (2025 to 2035)	8.9%

Semi Annual Market Update

Particular	Value CAGR
H1	9.6% (2024 to 2034)
H2	9.3% (2024 to 2034)
H1	8.9% (2025 to 2035)
H2	8.4% (2025 to 2035)

Country-wise Insights

Country	Value CAGR (2025 to 2035)
United States	2.3%
Germany	2.0%
Italy	2.5%
UK	4.6%
India	7.3%
China	6.8%

Category-wise Insights

Product	Value Share (2025)
Wheelchairs	57.4%

By Distribution Channel	Value Share (2025)
Online Retailers	39.5%

The global implantable medical devices market size reached USD 141.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 209.1 Billion by 2033, exhibiting a growth rate (CAGR) of 4.5% during 2025-2033. The rising prevalence of chronic diseases, increasing demand for smaller, more advanced implantable medical devices, and growing integration of digital health technologies and connectivity features in implantable devices are some of the key factors driving the growth of the market.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 141.3 Billion
Market Forecast in 2033	USD 209.1 Billion
Market Growth Rate 2025-2033	4.5%

IMARC Group provides an analysis of the key trends in each segment of the global implantable medical devices market report, along with forecasts at the global and regional levels from 2025-2033. Our report has categorized the market based on product type, material and end-user.

In the coming years the Asia Pacific reprocessed medical devices market is expected to reach USD 480.7 million by 2025 and is expected to steadily grow at a CAGR of 5.7% to reach USD 833.5 million by 2035. In 2024, cluster headache syndrome generated roughly USD 457.1 million in revenues.

Metric	Value
Industry Size (2025E)	USD 480.7 million
Industry Value (2035F)	USD 833.5 million
CAGR (2025 to 2035)	5.7%

Country Wise Analysis

Country	CAGR (2025 to 2035)
China	7.6%

Country	CAGR (2025 to 2035)
Japan	3.3%

Country	CAGR (2025 to 2035)
South Korea	6.6%

Country	CAGR (2025 to 2035)
India	8.1%

Country	CAGR (2025 to 2035)
Australia	2.9%

Competitive Outlook

Company Name	Estimated Market Share (%)
Stryker Corporation	(17-18)%
Medline Industries, Inc.	(14-15)%
Johnson & Johnson (Ethicon)	(11-12)%
Medtronic plc	(10-11)%
Other Companies (combined)	(43-44)%

The UAE Medical Device Market size was valued at around USD 1.92 billion in 2023 and is estimated to grow at a CAGR of about 8.87% during the forecast period, i.e., 2024-30.

The medical devices market is projected to grow at a CAGR of 7% from 2025 to 2030, driven by technological advancements, a rapidly growing aging population, and the rising prevalence of chronic diseases. Key factors fueling growth include increased healthcare expenditure, expansion of minimally invasive procedures, and rising adoption of digital health solutions like wearable […]

In 2021, the AI and machine learning medical device market was valued at around *** billion U.S. dollars globally. By 2032, the market was forecast to increase to a value of **** billion U.S. dollars.

Global connected medical devices market size & share predicted to reach USD 190.63 billion by 2032, to grow at a CAGR of 14.4% during the forecast period. The market for connected diagnostic imaging equipment is in a phase of notable expansion, fueled by the increasing demand for advanced and remote diagnostic capabilities.

• The industry was valued at US$ 27.6 Bn in 2022
• It is estimated to grow at a CAGR of 6.3% from 2023 to 2031 and reach US$ 47.4 Bn by the end of 2031

Pediatric Medical Devices Market Snapshot

Attribute	Detail
Market Size in 2022	US$ 27.6 Bn
Market Forecast (Value) in 2031	US$ 47.4 Bn
Growth Rate (CAGR)	6.3%
Forecast Period	2023-2031
Historical Data Available for	2017-2021
Quantitative Units	US$ Bn for Value
Market Analysis	It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape	Market share analysis by company (2022) Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format	Electronic (PDF) + Excel
Market Segmentation	Product In Vitro Diagnostic (IVD) Devices Cardiology Devices Diagnostic Imaging Devices Anesthesia & Respiratory Care Devices Neonatal ICU Devices Monitoring Devices Telemedicine Home-use Medical Devices End-user Hospitals Diagnostic Laboratories Ambulatory Surgical Centers Others
Regions Covered	North America Latin America Europe Asia Pacific Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Spain Italy Russia and CIS Japan China India ASEAN Brazil Mexico GCC South Africa
Companies Profiled	Abbott Boston Scientific Corporation Baxter International, Inc. Medtronic Cardinal Health, Inc. F. Hoffmann-La Roche Ltd. GE Healthcare Johnson & Johnson Siemens Healthinners Koninklikje Philips N.V. Stryker Corporation
Customization Scope	Available upon request
Pricing	Available upon request

BCC Research Report: Dive into emerging medical device market report presents a market analysis and estimates the CAGR(2021 and 2022) 2023 will be the base year, and 2024-2029 will be the forecasted year.

In 2023, Germany held the largest share of the medical device market in Europe. Standing at over 26 percent, the German medical device industry had a higher share than the closer two competitors, France and Italy, added together.

The Portable Medical Devices Market is Segmented by Product Type (Diagnostic Imaging Systems, Monitoring Devices [Cardiac Monitoring, and More], and More), Component (Sensors, Batteries & Power Modules, and More), Portability Type (Hand-Held, and More), End User (Hospitals, Physician Offices & Clinics, and More), and Geography (North America, Europe, Asia-Pacific and More). The Market Forecasts are Provided in Terms of Value (USD).

The antimicrobial-coated medical devices market size is projected to be valued at US$ 1,485.0 million in 2023 and is expected to rise to US$ 5,123.5 million by 2033. The sales of antimicrobial-coated medical devices are expected to register a significant CAGR of 13.2% during the forecast period.

Attribute	Details
Market Estimated Size (2023)	US$ 1,485 million
Market CAGR (2023 to 2033)	13.2%
Devices Market Forecasted Size (2033)	US$ 5,123.5 million

Scope of the Report

Attribute	Details
Growth Rate	CAGR of 13.2% from 2023 to 2033
Base Year of Estimation	2023
Historical Data	2018 to 2022
Forecast Period	2023 to 2033
Quantitative Units	Revenue in US$ million and Volume in Units and F-CAGR from 2023 to 2033
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis
Key Segments Covered	Device Type Coating Material By Region
Regions Covered	North America Latin America Europe East Asia South Asia The Middle East & Africa Oceania
Key Countries Profiled	The United States Canada Brazil Mexico Germany Italy France The United Kingdom Spain Russia China Japan India GCC Countries Australia
Key Companies Profiled	AST Products Inc. Covalon Technologies Ltd. BASF SE Bio Interaction Ltd. Royal DSM Sciessent LLC Specialty Coating Systems Inc. Hydromer Inc. Dow Chemical Company Biocote PPG Industries, Inc.
Customization & Pricing	Available upon Request

The global Medical Device Connectivity market size reached USD 1.55 Billion in 2021 and is expected to reach USD 11.17 Billion in 2030 registering a CAGR of 7.42%. Medical Device Connectivity market growth is primarily driven owing to increasingly stringent regulatory norms and requirements regardin...

Surgical and Medical Device Market Outlook

The global surgical and medical device market is projected to experience significant growth, with its market size estimated to reach approximately $650 billion by 2023, and a forecasted expansion to $1.1 trillion by 2032, reflecting a compound annual growth rate (CAGR) of approximately 6.3%. This growth is primarily driven by the increasing prevalence of chronic diseases, advancements in medical technology, and the rising demand for minimally invasive surgical procedures. Furthermore, the growing aging population and the expansion of healthcare infrastructure in emerging economies are anticipated to further fuel market growth throughout the forecast period.

One of the key growth factors for the surgical and medical device market is the rapid advancement in medical technology, which has led to the development of innovative and efficient devices. Technological advancements such as robotic-assisted surgeries, augmented reality in the operating room, and the integration of artificial intelligence in diagnostic imaging are transforming the landscape of surgical procedures. These innovations not only enhance the precision and outcomes of surgeries but also reduce recovery times, thereby increasing the demand for advanced surgical devices. Additionally, the continual research and development efforts by manufacturers to introduce cutting-edge products are further propelling market expansion.

The increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer is another significant driver of the surgical and medical device market. As these conditions often require surgical intervention, the demand for surgical devices and equipment is on the rise. According to the World Health Organization, non-communicable diseases are responsible for 71% of all deaths globally, underscoring the need for effective medical devices to manage these conditions. Furthermore, the growing awareness among patients and healthcare professionals about early disease detection and preventive healthcare is leading to a higher adoption of diagnostic and monitoring devices, further boosting market growth.

The expanding healthcare infrastructure in emerging economies presents a substantial opportunity for the surgical and medical device market. Countries in the Asia Pacific and Latin America regions are witnessing significant investments in healthcare facilities, aimed at improving accessibility and the quality of healthcare services. This expansion is accompanied by an increasing number of healthcare professionals and a growing focus on medical tourism, particularly in countries like India and Thailand. As a result, the demand for surgical and medical devices is expected to rise, providing lucrative opportunities for market players to expand their presence in these regions.

Regionally, North America currently dominates the surgical and medical device market, attributed to the presence of a robust healthcare system, high adoption of advanced technologies, and the presence of key market players. However, the Asia Pacific region is anticipated to witness the highest growth rate during the forecast period, driven by the factors mentioned earlier, such as expanding healthcare infrastructure and increasing medical tourism. In contrast, Europe is expected to experience steady growth, supported by the well-established healthcare sector and the rising geriatric population necessitating medical interventions. Meanwhile, the Middle East & Africa region is projected to witness moderate growth due to improving healthcare systems and investments in healthcare infrastructure.

The market for Used Medical Device Sales is also gaining traction as healthcare facilities and smaller clinics look for cost-effective solutions to equip their operations. This segment is particularly appealing in emerging markets where budget constraints often limit the acquisition of brand-new equipment. Used medical devices offer a viable alternative, providing essential functionalities at a fraction of the cost. Additionally, the refurbishment and resale of medical devices contribute to sustainability efforts by extending the lifecycle of equipment and reducing electronic waste. As the demand for healthcare services continues to rise, the market for used medical devices is expected to grow, offering opportunities for both sellers and buyers in the industry.

Product Type Analysis

The product type segment of the surgical and medical devic

The revenue is forecast to experience significant growth in all segments in 2029. As part of the positive trend, the revenue reaches the maximum value for all six different segments at the end of the comparison period. Particularly noteworthy is the segment Other Medical Devices, which has the highest value of *** billion U.S. dollars. Find further statistics on other topics such as a comparison of the revenue in Germany and a comparison of the revenue in France. The Statista Market Insights cover a broad range of additional markets.

Nitinol-based Medical Device Market Outlook

According to our latest research, the global nitinol-based medical device market size reached USD 18.7 billion in 2024, demonstrating robust expansion driven by technological advancements and increasing demand for minimally invasive procedures. The market is projected to grow at a CAGR of 8.2% from 2025 to 2033, reaching an estimated USD 37.2 billion by 2033. This remarkable growth trajectory is fueled by the unique properties of nitinol, such as superelasticity and biocompatibility, which are revolutionizing the landscape of medical devices across various specialties.

The primary growth factor for the nitinol-based medical device market is the increasing adoption of minimally invasive surgeries worldwide. Nitinol's superelastic and shape-memory capabilities have transformed the design and functionality of critical devices such as stents, guidewires, and catheters, making procedures less invasive and improving patient outcomes. As the global population ages, the prevalence of chronic diseases like cardiovascular disorders, orthopedic conditions, and dental issues continues to rise, further augmenting demand for advanced nitinol-based solutions. Additionally, ongoing innovation in device engineering and material sciences is enabling manufacturers to create next-generation products that address unmet clinical needs, thereby expanding the market’s scope and applicability.

Another significant driver is the surge in technological advancements and research investments in the medical device sector. Companies are leveraging nitinol’s biocompatibility and fatigue resistance to develop devices that offer superior performance and longevity. The integration of nitinol into orthopedic implants, dental devices, and neurological applications is broadening the market’s reach beyond traditional cardiovascular uses. Furthermore, collaborations between research institutions and industry players are accelerating the pace of innovation, resulting in a steady pipeline of new product launches and regulatory approvals. The increased focus on patient safety, faster recovery times, and reduced hospital stays is also bolstering the adoption of nitinol-based devices in both developed and emerging markets.

Healthcare infrastructure improvements and rising healthcare expenditure in developing economies are also playing a pivotal role in market growth. Governments and private organizations are investing heavily in upgrading hospital facilities and equipping them with state-of-the-art medical devices. This trend is particularly pronounced in Asia Pacific and Latin America, where rapid urbanization and rising disposable incomes are increasing access to advanced healthcare. The growing awareness among healthcare professionals about the benefits of nitinol-based devices is fostering their integration into clinical practice, further propelling market expansion. Additionally, favorable reimbursement policies and supportive regulatory frameworks are encouraging manufacturers to introduce innovative products, thereby enhancing the competitive landscape.

From a regional perspective, North America currently dominates the nitinol-based medical device market, accounting for the largest revenue share in 2024. This leadership is attributed to the presence of major market players, well-established healthcare infrastructure, and a high prevalence of chronic diseases. However, Asia Pacific is emerging as the fastest-growing region, driven by expanding healthcare access, increasing investments in medical technology, and a rising patient pool. Europe also holds a significant share, supported by government initiatives to promote advanced medical technologies and a strong focus on research and development. The Middle East & Africa and Latin America are witnessing steady growth, fueled by improvements in healthcare delivery and growing demand for minimally invasive interventions.

Product Type Analysis

The product type segment of the nitinol-based medical device market is char

The Self Care Medical Devices Market is Segmented by Type (Blood Glucose Monitors, Blood Pressure Monitors, Body Temperature Monitors, Nebulizers, Pedometers, Pregnancy/Fertility Test Kits, and Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Market Provides the Value (in USD Million) for the Above-Mentioned Segments.

Concerning the six selected segments, the segment Other Medical Devices has the largest revenue with ****** million U.S. dollars. Contrastingly, General & Plastic Surgery Devices is ranked last, with ****** million U.S. dollars. Their difference, compared to Other Medical Devices, lies at ****** million U.S. dollars. Find more statistics on other topics: a comparison of segments of the medical technology market in Mexico regarding the revenue.The Statista Market Insights cover a broad range of additional markets.

Wearable Medical Devices Market is predicted to USD 143.7 Billion by 2034 and CAGR 14.90% Market by Indications by Distribution Channels.